Skip to main content
. Author manuscript; available in PMC: 2020 Sep 1.
Published in final edited form as: Addict Behav. 2019 May 4;96:192–197. doi: 10.1016/j.addbeh.2019.04.032

Table 1.

FDA Research Priorities identified in the systematic review

FDA Research Priorities Number of
studies
 1. Behavior 48
  a. Use patterns
    i. Correlates/predictors of cigar use 36
    ii. Prevalence of use over time 12
   iii. Prevalence of use with the addition of brand names 6
   iv. Prevalence of use compared to blunt /marijuana use 4
    v. Prevalence of flavored cigar use 3
   vi. Other 2
  b. Perceptions 7
 2. Communications 4
  a. Mass media/public media campaigns 3
  b. Health warning labels 1
 3. Marketing influences 1
  a. Advertising restrictions 1
 4. Impact analysis 1
  a. Monetary cost, restrictions on use, youth access 1
 5. Toxicity 0
 6. Addiction 0
 7. Health Effects 0

Note: Studies can be included in more than one category.